Skip to main content

Indivior Pharmaceuticals, Inc.

INDV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001625297

In the last 90 days, Indivior Pharmaceuticals, Inc. insiders filed 2 open-market purchases and 1 sale; 337 institutions reported holding it in 13F filings for Q2 2026, worth $4.98B in total; Oaktree Capital is the only superinvestor holding it.

Holders of 5% or more of INDV

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Indivior Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of INDV
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock, Inc.13G/A14.30%17.8M shares+7.50 ppfrom 6.80%Jul 17, 20252 filingsJan 8, 2026SEC
Vanguard Portfolio Management LLC13G6.55%7.99M sharesNewApr 28, 20261 filingApr 28, 2026SEC
Oaktree Capital Holdings, LLC13D/A5.69%7.11M shares−1.31 ppfrom 7.00%Dec 18, 20244 filingsDec 30, 2025SEC
Vanguard Capital Management LLC13G5.35%6.52M sharesNewApr 27, 20261 filingApr 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

33 Schedule 13D and 13G filings on Indivior Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on INDV
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 15, 20269:18 AM ETMadison Avenue Partners, LPand 5 others13G/A3.50%4.32M shares−1.50 ppfrom 5.00%Below 5%Mar 31, 2026SEC
May 13, 20264:31 PM ETFuller & Thaler Asset Management, Inc.13G/A3.72%4.53M shares−1.38 ppfrom 5.10%Below 5%Mar 31, 2026SEC
Apr 28, 20262:06 PM ETVanguard Portfolio Management LLC13G6.55%7.99M sharesNewMar 31, 2026SEC
Apr 27, 20265:06 PM ETVanguard Capital Management LLC13G5.35%6.52M sharesNewMar 31, 2026SEC
Mar 23, 20265:19 PM ETMillennium Management LLCand 2 others13G3.80%4.81M sharesNewBelow 5%Mar 17, 2026SEC
Feb 17, 20264:57 PM ETMadison Avenue Partners, LPand 5 others13G/A5.00%6.28M shares−1.00 ppfrom 6.00%Dec 31, 2025SEC
Feb 17, 20261:37 PM ETFuller & Thaler Asset Management, Inc.13G5.10%6.37M sharesNewDec 31, 2025SEC
Feb 12, 202610:30 AM ETGoldman Sachs Group Incand 1 other13G/A2.90%3.59M shares−2.30 ppfrom 5.20%Below 5%Dec 31, 2025SEC
Jan 8, 20261:25 PM ETBlackRock, Inc.13G/A14.30%17.8M shares+7.50 ppfrom 6.80%Dec 31, 2025SEC
Dec 30, 20255:53 PM ETOaktree Capital Holdings, LLCand 6 others13D/A5.69%7.11M shares−1.31 ppfrom 7.00%Dec 24, 2025SEC
Dec 23, 20255:49 PM ETTwo Seas Capital LPand 2 others13D/A4.98%6.21M shares−0.72 ppfrom 5.70%Below 5%Dec 23, 2025SEC
Dec 22, 20254:19 PM ETMillennium Management LLCand 2 others13G2.00%2.46M sharesNewBelow 5%Dec 15, 2025SEC
Dec 10, 20258:15 PM ETTwo Seas Capital LPand 2 others13D/A5.70%7.06M shares−1.70 ppfrom 7.40%Dec 8, 2025SEC
Nov 13, 20259:15 PM ETOaktree Capital Holdings, LLCand 6 others13D/A7.00%8.75M shares−1.60 ppfrom 8.60%Nov 10, 2025SEC
Nov 13, 20254:27 PM ETFlynn James Eand 3 others13G/A3.70%4.61M shares−4.77 ppfrom 8.47%Below 5%Nov 10, 2025SEC
Nov 12, 20253:50 PM ETGoldman Sachs Group Incand 1 other13G/A5.20%6.53M shares−2.60 ppfrom 7.80%Sep 30, 2025SEC
Nov 5, 20258:21 PM ETTwo Seas Capital LPand 2 others13D/A7.40%9.25M shares−0.90 ppfrom 8.30%Nov 3, 2025SEC
Sep 5, 20254:13 PM ETTwo Seas Capital LPand 2 others13D/A8.30%10.3M shares−1.00 ppfrom 9.30%Sep 3, 2025SEC
Aug 13, 20255:48 PM ETGoldman Sachs Group Incand 1 other13G/A7.80%9.79M shares+1.30 ppfrom 6.50%Jun 30, 2025SEC
Jul 29, 20253:17 PM ETTwo Seas Capital LPand 2 others13D/A9.30%11.7M shares−0.40 ppfrom 9.70%Jul 25, 2025SEC
Jul 17, 20257:44 PM ETBlackRock, Inc.13G6.80%8.47M sharesNewJun 30, 2025SEC
Jul 14, 20252:27 PM ETTwo Seas Capital LPand 2 others13D/A9.70%12.1M shares0.00 ppfrom 9.70%Jul 10, 2025SEC
Jun 18, 20253:59 PM ETTwo Seas Capital LPand 2 others13D/A9.70%12.1M shares+0.20 ppfrom 9.50%Jun 17, 2025SEC
May 22, 20254:45 PM ETTwo Seas Capital LPand 2 others13D/A9.50%11.9M shares+0.20 ppfrom 9.30%May 20, 2025SEC
May 13, 20258:50 PM ETFlynn James Eand 3 others13G/A8.47%10.6M shares+1.31 ppfrom 7.16%Mar 31, 2025SEC
May 6, 20253:52 PM ETMorgan Stanleyand 1 other13G/A3.70%4.67M shares–Below 5%Mar 31, 2025SEC
Mar 18, 20256:43 PM ETMadison Avenue Partners, LPand 5 others13G6.00%7.44M sharesNewMar 11, 2025SEC
Mar 4, 20259:45 PM ETOaktree Capital Holdings, LLCand 6 others13D/A8.60%10.7M shares+1.00 ppfrom 7.60%Feb 28, 2025SEC
Mar 4, 20255:22 PM ETTwo Seas Capital LPand 2 others13D/A9.30%11.6M shares−0.30 ppfrom 9.60%Mar 3, 2025SEC
Feb 13, 20259:39 AM ETFlynn James Eand 3 others13G/A7.16%8.88M shares–Dec 31, 2024SEC
Feb 6, 20252:53 PM ETGoldman Sachs Group Incand 1 other13G6.50%8.09M sharesNewDec 31, 2024SEC
Jan 17, 20254:20 PM ETTwo Seas Capital LPand 2 others13D/A9.60%12.0M shares–Jan 15, 2025SEC
Dec 18, 20244:15 PM ETOaktree Capital Holdings, LLCand 7 others13D/A7.60%9.52M shares–Dec 16, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Indivior Pharmaceuticals, Inc. shares.

No Form 144 notices for Indivior Pharmaceuticals, Inc. are on file.